PATENT CLAIM ANALYSIS

Application Number: 15876401
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["549", "282000"]

Abstract:
Psoralen compounds of compounds having formulae 1A-10A, 1B-10B, 1C-10C, 1D-10D, 1E-10E, 1F-10F, 1G-10G, and 1H-5H as shown in FIG.  1,  and pharmaceutically acceptable salts thereof; and their use in methods for the treatment of a cell proliferation disorder in a subject, pharmaceutical compositions containing the psoralen derivatives, a kit for performing the method, and a method for causing an autovaccine effect in a subject using the method.

Claim (Index 13):
The method of  claim 1 , wherein the cell proliferation disorder is cancer.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.62
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11935655', '14603539', '14573511', '15786046', '13054279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7343083538904991
- 35 USC 102 Novelty (BERT): 0.5406074741636829
- Combined Prediction Score: 0.7149382659178174
- Mean Citation Score: 360.017622
- Max Citation Score: 367.34283
- Similarity Product: 315.77608829231684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test